ArticleChemphyschem : a European journal of chemical physics and physical chemistry2026
Boosting HER/OER Activity of Ni-FeOOH Through S and V Co-Doping.
Article in Chemphyschem : a European journal of chemical physics and physical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Rational manipulation of electronic structure and surface reaction energetics is essential for the development of high-performance bifunctional electrocatalysts for overall water splitting. Herein, a transition-metal doping method is proposed to systematically evaluate the activity of Ni-FeOOH modified with V, Nb, Zr, Mn, and Zn. A new S,V, co-doped Ni-FeOOH heterostructure supported on Ni foam is constructed, which induces redistributed electron density, regulated lattice strain, and enriched oxygen vacancies. As a result, the S,V, co-doped Ni-FeOOH catalyst exhibits outstanding oxygen evolution reaction (OER) performance with a low overpotential of 264 mV at 50 mA cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.